Effect of Soy Isoflavones Compared to Estradiol Valerate in Menopausal Women assessed by Menopause Quality of Life Questionnaire
Keywords:Menopause, Isoflavones, Estradiol, Estrogen replacement therapy, Hot flashes
BACKGROUND: There has recently been a global effort to develop preparations that aim for benefits of hormone replacement therapy with minimal discomfort or risk while isoflavones administration found to relieve complaints related to menopause and has been widely carried out.
AIM: The aim of the study is to determine the effect of soy isoflavone compared to estradiol valerate administration in postmenopausal women assessed by the Menopause Quality of Life (MENQOL) questionnaire.
METHODS: This is an experimental study with pre-post test non-randomized design using data from postmenopausal women who were divided into two groups, namely, group I Estradiol Valerate group which is 16 menopausal women were given Estradiol Valerate and group II Soy Isoflavone Supplements group which is 16 menopausal women were given Soy Isoflavone Supplements.
RESULTS: It was found that in estradiol valerate group, total MENQOL value before estradiol valerate administration was 81.56 ± 19.77, and after administration was 74.55 ± 16.82 with p = 0.002, which indicates there is a significant total MENQOL score difference before and after administration estradiol valerate. In the soy isoflavone group, the total MENQOL scores before soy isoflavone administration were 91.0 ± 16.31, and after administration was 83.08 ± 13.85 with p = 0.001, which indicated that there was a significant total MENQOL score difference between before and after administration soy isoflavone.
CONCLUSION: In comparison of menopausal complaints based on MENQOL scale in Estradiol Valerate and Soy Isoflavone groups after intervention, it was shown that there were significant differences in total MENQOL value after intervention.
Plum Analytics Artifact Widget Block
Ohta H. Hormone replacement up-to-date. Practical tips for hormone replacement therapy in women. Clin Calcium. 2007;17(9):1407-13. PMid:17767031
Carroll DG. Nonhormonal therapies for Hot flashes in menopause. Am Fam Physician. 2006;73(3):457-64. PMid:16477892
Siregar MF. Estradiol Serum Levels in Menopausal Women with and Without Vasomotor Syndrome in Medan; 2016. p. 67-87.
Kristen B, van Dole MA. The evaluation of the Menopause-Specific Quality of Life Questionnaire and Association of Vasomotor and Psychosocial Symptoms among Postmenopausal Women in the United States: Dissertation. The United States: University of North Carolina at Chapel Hill; 2009.
Harper-Harrison G, Shanahan MM. Hormone Replacement Therapy. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2018.
NAMS. The role of soy isoflavones in menopausal health: Report of American Menopause society. J N Am Menopause Soc. 2010;72(6):527-31.
Hartati R, Satiyem S, Wiyasa IW, Nurdiana N, Kalsum U, Arifiandi MD, et al. The Correlation between Estradiol, 25 Hidroxyvitamin D and Quality of Life among Postmenopausal Women, International Conference on Life Sciences and Technology; 2020. p. 1-7.
Xue W, Sun AJ, Zheng TP, Jiang JF, Wang YP, Zhang Y, et al. Analysis of the effects on menopausal symptoms, quality of life, and cardiovascular risk factors of five different therapy in women at early stage of menopause. Zhonghua Yi Xue Za Zhi. 2016;96(29):2327-11. http://doi.org/10.3760/cma.j.issn.0376-2491.2016.29.009 PMid:27524190
Mirkin S, Graham S, Revicki DA, Bender RH, Bernck B, Constantine GD. Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone. Menopause. 2019;26(6):637-42. http://doi.org/10.1097/GME.0000000000001294 PMid:30601452 DOI: https://doi.org/10.1097/GME.0000000000001294
Komm BS, Mirkin S. The tissue selective estrogen complex: A promising new menopausal therapy. Pharmaceuticals (Basel). 2012;5:899-924. http://doi.org/10.3390/ph5090899 PMid:24280697 DOI: https://doi.org/10.3390/ph5090899
Lee H, Choue R, Lim H. Effect of soy isoflavones supplement on climacteric symptoms, bone biomarkers, and quality of life in Korean postmenopausal women: A randomized clinical trial. Nutr Res Pract. 2017;11(3):223-31. http://doi.org/10.4162/nrp.2017.11.3.223 PMid:28584579 DOI: https://doi.org/10.4162/nrp.2017.11.3.223
Chen LR, Ko NY, Chen KH. Isoflavone supplements for menopausal women: A systematic review. Nutrients. 2019;11(11):2649. http://doi.org/10.3390/nu11112649 PMid:31689947 DOI: https://doi.org/10.3390/nu11112649
Peng CC, Liu CY, Kuo NR, Tsung TH. Effects of phytoestrogen supplement on quality of life of postmenopausal women: A systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2019;2019:3261280. http://doi.org/10.1155/2019/3261280 PMid:31057646 DOI: https://doi.org/10.1155/2019/3261280
Lumbanraja IL. Efek Pemberian Soy Isoflavone Terhadap Keluhan Urogenital, Indeks Maturasi Vagina, dan Fungsi Seksual Wanita Menopause, USU; 2021. Available from: http://www.repositori.usu.ac.id/handle/123456789/32725 [Last accessed on 2021 Jul 17].
How to Cite
Copyright (c) 2022 Willy Kurnia Almon, Muhammad Fidel Ganis Siregar, M. Rhiza Z. Tala, Makmur Sitepu, Ichwanul Adenin, Muara Panusunan Lubis (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.